A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

NCT01750190 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)

NCT00782561 ·Status: TERMINATED ·Phase: PHASE1

An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD

NCT02228655 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

NCT01414075 ·Status: COMPLETED ·Phase: PHASE2

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04621331 ·Status: WITHDRAWN ·Phase: PHASE3

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

NCT00761657 ·Status: COMPLETED ·Phase: PHASE2

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

NCT01147666 ·Status: COMPLETED ·Phase: PHASE2

Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT02534909 ·Status: COMPLETED ·Phase: PHASE2

REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate Its Long Term Safety, Efficacy and Tolerability.

NCT04162470 ·Status: TERMINATED ·Phase: PHASE3

A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD

NCT01873534 ·Status: TERMINATED ·Phase: PHASE2

Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04925011 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 ·Status: COMPLETED ·Phase: PHASE3

Study of GBT021601 in Participants With Renal Impairment

NCT05878704 ·Status: TERMINATED ·Phase: PHASE1

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

NCT04059913 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

NCT02174627 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 ·Status: TERMINATED ·Phase: PHASE2

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

NCT02492620 ·Status: COMPLETED ·Phase: PHASE3

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

NCT02260193 ·Status: COMPLETED ·Phase: PHASE2

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

NCT01736397 ·Status: COMPLETED ·Phase: PHASE2

Study of Aldafermin (NGM282) in Participants With Impaired Renal Function

NCT04179630 ·Status: COMPLETED ·Phase: PHASE1

Peginesatide for Anemia in Chronic Hemodialysis Patients

NCT00228449 ·Status: COMPLETED ·Phase: PHASE2

A Crossover Safety Study of Ferumoxytol Versus Placebo

NCT00255450 ·Status: COMPLETED ·Phase: PHASE3

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

NCT01151592 ·Status: WITHDRAWN ·Phase: PHASE4

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

NCT06295770 ·Status: RECRUITING ·Phase: PHASE2